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AbstrACt 
background The use of medication is at the heart of primary care, but is also the 
cause for major health concerns. It is therefore important to examine the prescrip-
tion of medication process. 
Objective This study identifies the barriers and facilitators perceived by commu-
nity pharmacists and primary care physicians concerning the adoption of a nation-
wide electronic prescribing (e-prescribing) network in the province of Quebec, 
Canada. 
Methods We used purposive sampling to identify the most intensive users of the 
e-prescribing network. We conducted phone and in-person interviews. Interviews 
were transcribed, and we analysed their content with NVivo, using the clinical adop-
tion framework (CAF) for the codification of the data. 
results We interviewed 33 pharmacists, 2 pharmacy technicians, 11 physicians 
and 3 clinic managers. Adoption of the e-prescribing network was fairly low. The 
respondents underlined adaptation of their work environment, openness to change 
and perception of benefits as facilitators to the adoption of the network. However, 
important barriers were perceived, including system quality issues and paper pre-
scriptions being the only legal document in the prescribing process. Even if respon-
dents recognised that the e-prescribing network can offer substantial benefits to the 
prescribing process, issues still persisted and raised barriers to the full use of such 
a network, especially in a context where different local information systems are con-
nected within a nationwide e-prescribing network. 
Conclusion This study, based on the CAF, provides a better understanding of the 
factors related to the adoption of a nationwide e-prescribing network connecting 
primary care clinics and community pharmacies.
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IntrOduCtIOn
The use of medication is at the heart of primary care, but 
is also the cause of major concerns, notably in terms of 
patient safety. Indeed, medication usage is a complex 
 process, involving multiple actors, and it is prone to errors.1 
 Drug-related illnesses are amongst the most common medi-
cal adverse events and are one of the leading causes of 
 mortality.2,3 According to the O’Hagan et al.4 study on 
 self-reported medical errors in USA, Australia, Canada, 
Germany, the Netherlands, New Zealand and UK, at least 
one  respondent on ten for each country believed that he or 
she experienced medical or medication errors in the past 
two years. Yet these are often the kinds of errors that are 
preventable.3,5–7 Therefore, it is important to improve the 
processes related to the medication use in primary care, 
notably prescribing and processing.8,9 The computerisation 
of these processes, with the help of information and com-
munication technologies, is a path that numerous countries 
have followed.10 
The use of advanced features of electronic prescribing 
(e-prescribing) enables the exchange of medication data 
between a prescriber and a pharmacist, as opposed to first-gen-
eration e-prescribing that only allows an electronic application 
for entry, modification and review of prescription.11 Second-
generation e-prescribing enables safe electronic sharing of a 
patient’s prescription between an authorised prescriber and a 
retail pharmacy through the use of an e-prescribing applica-
tion or a pharmacy management software12,13 and dispensed 
medication data can be shared by the pharmacy manage-
ment software through claims14 or a medication database.15 
Thus, e-prescribing has the potential to improve the quality, 
safety and efficiency of care; it could also be cost effective 
for the health system and reduces medication errors6,14,16–19 
by acting on poor handwriting and on the lack of communi-
cation between professionals.20 Even so, the implementation 
and adoption of e-prescribing is still poor, particularly in the 
North American context.16,17,21,22 Previous studies have docu-
mented the implementation and adoption of e-prescribing in 
primary care,23 but research on the topic is still limited, par-
ticularly among health professionals other than physicians23,24 
and on the second generation of e-prescribing.11
In Canada, Health Canada announced in 2007 that 
there was no impediment to e-prescribing and that elec-
tronically generated and transmitted prescriptions are per-
missible as long as they achieve the same objectives as 
written prescriptions.20,25 Despite this, electronic prescribing 
is still not widely adopted in the country. Indeed, only 43% 
of Canadian family physicians routinely use electronic pre-
scribing,26 and of those, many solely enter their prescrip-
tion electronically in their electronic medical record (EMR) 
in order to print or fax the prescription. Nonetheless, the 
use of electronic prescribing is increasing in Canada.26 
This study examines the province of Quebec’s nation-
wide e-prescribing network, the first initiative of the kind in 
the country. 
Quebec e-prescribing network
Quebec’s e-prescribing network is a second-generation 
e-prescribing system that consists of a central repository 
separated in two data warehouses: 1) the e-prescription 
warehouse and 2) the medication history warehouse. 
Prescribers can send their prescription data to the e-pre-
scription warehouse from the prescription module of their 
EMR. The pharmacist or pharmacy technician from the 
pharmacy chosen by the patient can then ‘pull’ the data from 
the e-prescription warehouse into its pharmacy manage-
ment software using the patient’s health insurance number, 
a unique nationwide identifier. Moreover, all the dispensed 
medications are added to the medication history warehouse 
automatically when entered in the pharmacy medication 
management software. This warehouse is accessible by 
both the prescriber and the pharmacist for viewing through 
their respective local information systems or by using an 
Internet browser. Finally, physicians can import the data 
from the medication history for prescription renewals or 
other clinical purposes. At the time of the study, every per-
son with principal residency in the first four regions where 
the e-prescribing network has been deployed and who are 
covered by the provincial universal health insurance plan 
are registered in the e-prescribing network, unless they 
have chosen to opt out.27 
Keywords: adoption factor, clinical adoption framework, electronic prescribing, 
pharmacists, physicians, primary care
Where this study fits in?
Electronic prescribing could improve the processes related to the use and dispen-
sation of drugs in health care, but their adoption is still poor in the North American 
context. Research on the topic of adoption of electronic prescribing is still lim-
ited, particularly among health professionals other than physicians. This study, 
based on the clinical adoption framework (CAF), provides a better understanding 
of the factors related to the adoption of a nationwide electronic prescribing net-
work connecting primary care clinics and community pharmacies in the province 
of Quebec, Canada. 
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The aim of this study was to identify the barriers and facili-
tators perceived by community pharmacists and primary care 
physicians with respect to the implementation and adop-
tion of a nationwide e-prescribing network in the province of 
Quebec, Canada.
MAterIAls And MethOds
setting and participants
The sample was selected through purposive sampling in 
order to identify the most intensive users of the e-prescrib-
ing network. At the beginning of 2013, we targeted primary 
care clinics and community pharmacies that had the highest 
levels of usage of e-prescriptions through the e-prescribing 
network, according to the data obtained from the provincial 
universal health insurance board. Users were contacted 
by phone at their workplace. Letters of support were given 
by the Quebec Association of General Physicians and the 
Quebec Association of Pharmacists–Owners to help us 
contact clinic managers and pharmacists, respectively. In 
total, 24 medical clinics and 41 pharmacies were contacted. 
The study received approval from the CHU de Québec 
Research Centre’s ethical committee prior to the recruit-
ment of respondents.
data collection and analysis
We conducted semi-structured interviews in person or by 
phone between February and September 2013, depending on 
the participant’s preference. The interview guide consisted of 
three main themes: respondents’ experience regarding use 
of the e-prescribing network, issues related to the network 
and benefits to the use of the network. Informed consent was 
obtained from all the respondents, and financial compensa-
tion was offered to them for their time.
Interview content was transcribed and analysed with 
the support of the qualitative data analysis computer soft-
ware NVivo.28 We used the CAF proposed by Lau et al.29 
for the codification of interview content (see Figure 1). The 
CAF makes it possible to classify adoption factors of health 
information systems by clinicians.29 This model categorises 
adoption factors according to three levels: micro (net ben-
efits; use; user satisfaction; system, information and ser-
vice quality); meso (people; organisation; implementation) 
and macro (standards; legislation; policy and governance; 
funding and incentives; societal, political and economic 
trends).29,30 We analysed phone and in-person interviews 
since there was no noticeable differences between the two 
sets of interviews.
results 
In total, we interviewed 49 persons (19 face to face and 
30 by phone). Table 1 presents the socio-demographic 
characteristics of the respondents. Community pharma-
cists accounted for a majority of respondents (67%). The 
respondents were part of two different waves of imple-
mentation of the e-prescribing network. The first wave, 
represented by 20 respondents, began in 2008 and was 
completed in 2010. While many pharmacies were con-
nected at the beginning of the implementation of the e-pre-
scribing network, it took a longer time for medical clinics 
to come onboard and for patients to be registered in the 
network, leaving a gap in the medication data available in 
the network. The second wave, represented by 29 respon-
dents, began at the end of 2011 and was more uniform, 
having both clinics and pharmacies concurrently con-
nected, as well as having a more complete compilation of 
patients’ profiles upon implementation. Since the respon-
dents came from the first establishments that adopted the 
e-prescribing network in the province, we can consider 
them as early adopters to the network. 
Even if we recruited professionals from pharmacies and clinics 
that had the highest levels of usage of e-prescriptions, respon-
dents reported a very low use of the e-prescribing network.31 
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The underutilisation of the network was caused by many 
 barriers to adoption common to pharmacists and physicians, 
and these barriers are mostly related to system quality.
Issues with system quality
A recurrent and critical problem mentioned by professionals 
was the lack of data standardisation that led to inadequate 
data importation and exportation, especially concerning 
medication instructions. Not only did these instructions need 
to be modified manually, but pharmacists also had to modify 
medication names so that they would correspond with their 
inventory and patient insurance claims. Subsequently, this 
was also a problem for physicians. Indeed, this modified list 
was automatically sent to the nationwide medication history 
warehouse, and then retrieved by the physician who was 
confronted with medication names that did not match his or 
her initial prescription. 
Respondents also reported a lack of interoperability 
between their local information systems as an irritant as 
regard the use of e-prescribing. Physicians and pharmacists 
had to use a second application or screen to have access 
to the e-prescribing network since it was not integrated in 
their information system. Physicians that used the network 
during the early stages also noted that the time lag before 
automatic log out from the network was too short. However, 
this problem was resolved before the end of our study, 
as pointed out by the last respondents. Physicians added 
that there were important delays in network transmission. 
Indeed, each medication on the prescription was sent one 
at a time to the e-prescribing network. A single transmission 
could take a few seconds. While a few seconds accounted 
for little individually, they added up at the end of a day. 
These interoperability problems led to an important loss of 
time and accentuated risks of error, which were seen as 
powerful barriers to the use of the e-prescribing network by 
respondents.
The waves of implementation of the e-prescribing net-
work also affected system quality, to the detriment of the 
first wave. During the first wave of implementation, a large 
number of pharmacies were connected to the network, 
thus sending their dispensing data, but very few physicians 
were connected to it. This situation led to a shortage of pre-
scriptions in the e-prescription warehouse, which often led 
to the underutilisation of the e-prescription warehouse by 
pharmacists. On the other side, it seemed that the more 
recent implementation and a shorter time lag in the cadence 
of connections of pharmacies and clinics during the sec-
ond wave led to a greater perceived usefulness among pro-
fessionals, which has facilitated their adoption. However, 
respondents from both waves underlined the importance of 
rapidly expand the e-prescribing network to other regions 
and to hospitals, so more information might become avail-
able in the network.
Nonetheless, some functions of the e-prescribing net-
work worked well and benefited physician and pharmacists’ 
work. In general, respondents believed that consultation of 
the medication history warehouse was easy to carry out and 
functional. E-prescribing also made prescriptions more leg-
ible. The automatic transmission of data from pharmacies 
to the nationwide medication history warehouse and the 
streamlining of the renewal process in clinics were the func-
tionalities most appreciated by respondents. In addition, most 
respondents noted that data from the nationwide medication 
history warehouse were useful to complete patient files and 
table 1. respondents’ characteristics 
Respondents’ Characteristics
All Respondents
(n = 49)
N %
Role
Physician 11 22.4
Primary care clinic manager 3a 6.1
Pharmacist 33 67.3
Pharmacy technician 2 4.1
Setting
Primary care clinic 14 28.6
Community pharmacy 35 71.4
Gender
Female 23 46.9
Male 26 53.1
Implementation wave
First wave 20 40.8
Second wave 29 59.2
aOne of the three managers is also a physician
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could warn the user in case of patients with potential drug 
abuse problems.
effects of system quality on other factors
System quality issues had effects on other factors reported 
by the participants. Individually, most physicians did use the 
e-prescribing module included in their EMR, but few trans-
mitted their prescription through the network or consulted 
the data from the medication history warehouse. Since the 
use of the network was an individual and voluntary act for 
physicians, many preferred to remain disconnected to avoid 
the issues related to the system. Consequently, information 
contained in the nationwide e-prescription warehouse was 
often incomplete, outdated or not available for pharmacists. 
By adding implementation issues to this situation, the lack 
of available or complete information due to few prescrip-
tions sent through the network was a strong factor in demo-
tivating pharmacists. However, they asserted that patient 
information was becoming increasingly available in the 
medication history warehouse, suggesting an improvement 
in the situation.
Reluctance from pharmacists caused by the system qual-
ity issues was less apparent. The earlier computerisation of 
community pharmacies’ local work environment and regu-
lar use of electronic local pharmacy software facilitated the 
adoption of the e-prescribing network. Moreover, the auto-
matic exportation of data to the nationwide medication his-
tory warehouse was imposed as soon as a pharmacy was 
connected to the network.
Finally, we observed that openness to change was impor-
tant in the adoption of e-prescribing since people who were 
ready to invest time and effort in the appropriation of the net-
work were the ones who believed that it was a solution for the 
future. However, even if the early adopters were convinced of 
the potential benefits of the e-prescribing network, it seemed 
difficult to maintain their motivation over time because of the 
lack of perceived added value following the use of the net-
work, particularly because of the numerous barriers related 
to system quality.
Other factors influencing e-prescribing 
adoption
Some other factors hindered the adoption of the e-prescrib-
ing network in clinics and pharmacies. First, pharmacists 
and physicians noted a lack of training in the use of the 
e-prescribing network. In particular, respondents mentioned 
training periods that were too short, lack of training following 
implementation and the absence of training for pharmacy 
technicians. This has resulted in incomprehension when 
using the network, a gap in the use of advanced functional-
ities of the transmission of prescriptions and ultimately, the 
underutilisation of the network. However, the training was 
judged sufficient by a minority of pharmacists, who even 
specified that it was possible for them to receive updates 
if needed.
Additionally, the technical support received by the phar-
macies from their software provider was problematic. First, 
respondents perceived that technical support and follow-
up were minimal and far from satisfactory. Most of them 
believed that the IT technicians lacked the expertise to fully 
understand the specifics related to the e-prescribing net-
work. Moreover, delays in customer service could be very 
long, preventing the user from performing his or her usual 
tasks in the meantime.
Having a paper order as the only legal document in the 
e-prescribing process also appeared as a significant barrier 
to the use of the network since it required patients to bring 
their paper prescription with them to the pharmacy even if an 
electronic version of the prescription was available through 
the network. It also legitimised a hand process of prescription 
that remained based on the information found on the paper 
prescription, and then transferred manually to the local phar-
macy system. 
Conversely, other important factors facilitated the adop-
tion of the network in the primary care clinics. Indeed, 
some clinics have successfully opted for the involvement 
of all their clinicians in the system implementation and for 
the presence of an on-site champion who could support 
physicians in their use of the system in order to favour 
a large as possible use. These two strategies seemed to 
greatly facilitate the implementation of the network in the 
clinics. Also, the provincial government offered a financial 
incentives program to support the computerisation of pri-
mary care clinics. It was seen as a facilitator to the adop-
tion of the e-prescribing network by physicians since the 
transmission of medication information to the network was 
among the six functionalities that had to be used by physi-
cians in order for them to benefit from the incentive pro-
gram. Table 2 summarises the factors identified, classified 
by themes from the CAF, and presents selected quotes 
from the interviews.
dIsCussIOn
Principal findings
This study highlighted key issues concerning the barriers and 
facilitators perceived by community pharmacists and primary 
care physicians with respect to the implementation and adop-
tion of a nationwide e-prescribing network. 
Adoption of the e-prescribing network was far below 
the initial expectations. Even if all the participants came 
from clinics and pharmacies that were the highest users 
of the network, its use was still very low among them. 
For physicians, such use seems to follow the tendency of 
health-related technologies use in the province. Indeed, 
physicians from the province of Quebec are the lowest 
users of electronic tools for patient care in Canada.32 
Respondents recognised that the e-prescribing network 
can offer substantial benefits to the prescribing process 
but issues still persist and raise barriers to the full use of 
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table 2. Adoption factors and selected quotes from respondents classified by CAF themes
Related Theme Quotea
System quality
Standardisation It does not work. First, the e-prescribing network is not in my EMR. It’s a different screen. So when I have 22 
pills [the respondent names a few commercial ones], and here it is named [name other pills, generic ones this 
time], and then you have a cream I didn’t prescribe. So, to go from one to another, to compare, it just doesn’t 
work. They are not in the same order. I’m unable to say if the dosage of Lasix 20 is the same as the diuretic 
20mg. The terms are not the same. It requires a lot of energy. (Physician)
Interoperability Since the e-prescribing network is extern to the EMR, you always have to go out of the EMR and go in another 
application. It is tiring; to open it and then you need a password. It is never-ending. (Physician)
Working functions The aspects of visualization, user-friendliness and screen consultation [of the medication history] are all going 
well. No complaints. It goes well with what you use on an everyday basis. (Pharmacist) 
Implementation
Implementation planning For sure, the implementation planning was not the best. They should have implemented it with an eye towards 
the north, Toward the surrounding regions. I have a lot of clients of a [neighbour region] physician. I asked 
them, ‘What is the logic behind doing only our region, but not the others?’ It made no sense whatsoever. 
(Pharmacist)
Education and training There was a training session. I don’t remember how many hours, an afternoon I believe. Either I did not 
understand or the explanation was poor, but I didn’t understand what the goal of the e-prescribing network 
really was. There was no relaunch or follow-up, at least not for me. (Physician)
Organisation
Computerisation The pharmacy began its computerizing process almost 30 years ago if I remember correctly. It has been a long 
time. I never learned the old method. The physicians are beginning that process. But we have always known 
how to handle that. (Pharmacist)
Technical support Waiting on the phone [for technical support] was very long and sometimes the line would be busy. I was there 
two times it happened, so the second I knew what to do. I just deactivated the link to the network. I asked 
them why I had to do that. And they said ‘It’s a mystery’. They also said that they would call us back to 
reactivate it and they never did. It’s me, at the end of the day that tried it to know if it functioned, and it did. 
(Pharmacy technician)
Involvement of clinicians We took the decision to use more and more the EMR, and it also implies the e-prescribing network. Everyone is 
okay with the idea. Does everyone adapt to the EMR and the network at the same time? Definitely not. But 
there is a strong trend in the clinic. We even fixed a date later this year where everyone needs to have entered 
their notes electronically in their EMR. (Physician)
On-site champion What you need is a champion per clinic. If a clinic does not have a computer champion, they need a volunteer 
that will be trained. And this person need to be available and interested to help their colleagues, at any time. 
You need to be ready to say to your patient: ‘Wait for me, I will go help a colleague with an issue. I will come 
back’. (Physician)
People
Openness to change The owners did it out of curiosity. To be at the forefront also. It’s a new thing and we wanted to test its potential. 
[…] We gave a lot of comments to the company on how it was working. This is why we brought the 
e-prescribing network. We were eager to see what it was and to use it. (Pharmacist)
Perception of benefits It is good as long as the data are there and reliable. If you have unreliable or obsolete data, or you don’t have 
any data at all, then the e-prescribing network is not worth a thing. There’s nothing in it for you. (Physician)
Funding and incentive
Financial incentives There is an incentive. You know there is a program in Quebec for EMR adoption that provides financial incentives 
for physicians for familiarization with all of that. There is a part that is provided initially, and the other part is 
given only if you use six of the twelve functionalities of the EMR. And one of these functionalities is to use the 
e-prescribing network. So there is a motivation there. If physicians want their money by using the network in 
their EMR. (Physician) 
Legislation, policy and 
governance
Paper prescription Anyway, even electronic [prescription], is not legal. We need the paper. I cannot just go and retrieve the 
prescription through the e-prescribing network. (Pharmacist) 
aAll the quotes were translated from French
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such a network, especially in a context where different 
local information systems are connected within a nation-
wide e-prescribing network.
Comparisons with the literature
Many factors highlighted in our study are also present in the 
literature on e-prescribing adoption. Our results echo those 
from other studies and underline the importance of champi-
ons on the field,8 support and training,5,21,33 positive attitude 
toward the technology,22,33,34 improved workflow,2,35,36 infor-
mation access,17,21 organisational support37 and financial 
incentives38 to facilitate the implementation of e-prescribing. 
The respondents also identified early computerisation of the 
work environment and automatic transmission of data as 
facilitators to its implementation.
A number of reasons can explain the underutilisation 
of the e-prescribing network. In this study, factors that 
were perceived as more crucial in the adoption of the net-
work were related to system quality and were also identi-
fied in the literature: issues with interoperability between 
the systems,6,39,40 access to useful additional informa-
tion that are not yet available in the nationwide system, 
such as  laboratory results17,21,35,38,39,41 and lack of data 
 standardisation.11,17,24,34 This last issue compromises the 
security of the patient and may be dangerous if not prop-
erly addressed. There were also other crucial issues that 
were raised by the respondents but not underlined in the 
literature, notably the lack of legal autonomy for the e-pre-
scription without the paper order signed by a physician and 
the uneven implementation of the e-prescribing network. 
These issues led the professionals to perceive more disad-
vantages than advantages in the use of the network and this 
ultimately led to its abandoning.
limitations of the study
This study has some limitations. First, despite numerous 
efforts, it was more difficult to recruit physicians than phar-
macists, even if all the connected clinics were contacted 
to solicit their participation. We think that data saturation 
was achieved42 among pharmacists, but data saturation 
was less evident with physicians. Nonetheless, the physi-
cians’ comments were very consistent from one physician 
to another and were also in line with observations coming 
from pharmacists. It would be useful to complement the 
results of this study with more information regarding the 
experience of primary care physicians with the e-prescrib-
ing network.
Second, we conducted this study with the two first 
waves of implementation of a nationwide e-prescribing 
network. Perhaps, the implementation process may 
improve with experience, and future users will develop 
more realistic expectancies. Even if the first two waves 
showed some variations in their implementation pro-
cesses, the study offers results that are in line with the 
evidence-based literature in the domain. So, we believe 
that this study provides valid findings that are representa-
tive of the experience of the network adoption all the more 
so that it concerned early adopters. These adopters are 
important because they act as opinion leaders, and their 
attitude toward new technologies is critical to successful 
implementation. 
Third, our recruitment targeted clinics and pharmacies with 
the most frequent users and early adopters of the e-prescrib-
ing network. It would also be important to study non-users 
and infrequent users in order to develop a broader overview 
of the barriers to adoption and use of the network. However, 
we believe that focusing on these early users provides a sig-
nificant and pertinent understanding of the issues related to 
the early stage of a nationwide e-prescribing network imple-
mentation and adoption.
Call for future research
There is still little research on e-prescribing systems in pri-
mary care and even less on the interoperability between 
a nationwide e-prescribing network and other local infor-
mation systems that are present in health care facilities. 
Future research should look into these interoperability 
issues when e-prescribing and information systems are 
interconnected with a provincial or national level e-pre-
scribing network.
COnClusIOn 
The CAF used in this study was helpful in explaining the fac-
tors influencing the adoption of a nationwide e-prescribing 
network among physicians and pharmacists in a context 
where different local information systems are connected. 
Currently, the e-prescribing network can offer substantial 
benefits to health care professionals. However, significant 
barriers hinder the implementation and use of this network. 
It would be important to stimulate the interest of potential 
network users by working on the issues identified in this 
study, especially when these issues are highlighted by early 
adopters of the system. 
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